搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Daily
10 小时
Roxadustat effective in patients with CKD with varying blood CRP levels, reveals research
A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...
Taiwan News
22 小时
Chronic Kidney Disease Treatment Market Size, Overview, Share, Trends, Demand, Research ...
The prevalence of chronic kidney disease is rising globally, with millions of individuals affected. Factors such as renal illnesses, diabetes, and hypertension contribute to the growing incidence, ...
Daily
3 天
Sleep disorder and chronic kidney disease may have Bidirectional association, unravels study
A new meta-analysis published in the recent issue of Clinical Kidney Journal revealed a significant bidirectional ...
Medpage Today on MSN
7 天
Study: CKD Not Worsened With Gout Treatment
Some 20% to 30% of gout patients also have CKD, the researchers said, which is not surprising since they share many risk ...
1 天
on MSN
Numerous factors can cause kidney disease. Here are the most common ones.
AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...
Medscape
16 小时
Sotagliflozin Helps Manage Anemia in Patients With Type 2 Diabetes and Chronic Kidney Disease
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
2 天
on MSN
Water project to combat CKD on fast-track in Andhra
VIJAYAWADA: The authorities are fast-tracking a drinking water project in A Konduru mandal to provide safe Krishna water to ...
12 天
Study shows risk for emergently treated hypocalcemia with denosumab rises with CKD stage
For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...
clinicaltrialsarena
14 天
AHA 2024: GLP-1R agonist associated with better clinical outcomes in heart failure and CKD
At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.
1 天
Nephrology conference focuses on home peritoneal dialysis for CKD patients
Home peritoneal dialysis, a widely recognised form of home dialysis, enables patients to manage their treatment in the comfort of their homes ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈